BioRestorative Therapies, Inc. (BRTX) develops therapeutic products using cell and tissue protocols, primarily involving adult stem cells. Its lead product, BRTX-100, is an autologous mesenchymal stem cell therapy in Phase 2 clinical trials for chronic lower back pain from degenerative disc disease. It also runs the ThermoStem Program for metabolic disorders using brown adipose stem cells, and operates a commercial biocosmeceutical platform producing a cell-based secretome serum.
Q2 FY2026 — expected 2026-09-15
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-26 | 2025-12-31 | 0001493152-26-012925 | EDGAR | 71K words |
| 2025-03-28 | 2024-12-31 | 0001641172-25-001011 | EDGAR | — |
| 2024-04-01 | 2023-12-31 | 0001493152-24-012056 | EDGAR | — |
| 2023-03-27 | 2022-12-31 | 0001493152-23-008960 | EDGAR | — |
| 2022-03-30 | 2021-12-31 | 0001493152-22-008184 | EDGAR | — |
| 2021-04-30 | 2020-12-31 | 0001493152-21-010062 | EDGAR | — |
| 2021-03-18 | 2019-12-31 | 0001493152-21-006285 | EDGAR | — |
| 2019-03-29 | 2018-12-31 | 0001493152-19-004292 | EDGAR | — |
| 2018-04-02 | 2017-12-31 | 0001493152-18-004554 | EDGAR | — |
| 2017-03-22 | 2016-12-31 | 0001493152-17-002701 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-12 | 2025-09-30 | 0001493152-25-021993 | EDGAR | 18K words |
| 2025-08-12 | 2025-06-30 | 0001641172-25-023211 | EDGAR | — |
| 2025-05-14 | 2025-03-31 | 0001641172-25-010299 | EDGAR | — |
| 2024-11-12 | 2024-09-30 | 0001493152-24-044763 | EDGAR | — |
| 2024-08-13 | 2024-06-30 | 0001493152-24-031636 | EDGAR | — |
| 2024-06-11 | 2024-03-31 | 0001493152-24-023481 | EDGAR | — |
| 2023-11-13 | 2023-09-30 | 0001493152-23-040483 | EDGAR | — |
| 2023-08-11 | 2023-06-30 | 0001493152-23-027825 | EDGAR | — |
| 2023-05-12 | 2023-03-31 | 0001493152-23-016630 | EDGAR | — |
| 2022-11-14 | 2022-09-30 | 0001493152-22-031668 | EDGAR | — |
| 2022-08-15 | 2022-06-30 | 0001493152-22-022617 | EDGAR | — |
| 2022-05-16 | 2022-03-31 | 0001493152-22-013396 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-02-17 | 0001493152-26-006837 | EDGAR | 5K words |
| 2025-11-12 | 0001021771-25-000148 | EDGAR | — |
| 2025-10-08 | 0001493152-25-017446 | EDGAR | — |
| 2025-09-25 | 0001021771-25-000131 | EDGAR | — |
| 2025-08-14 | 0001021771-25-000116 | EDGAR | — |
| 2025-08-12 | 0001021771-25-000113 | EDGAR | — |
| 2025-06-13 | 0001021771-25-000092 | EDGAR | — |
| 2025-05-14 | 0001021771-25-000079 | EDGAR | — |
| 2025-04-21 | 0001021771-25-000074 | EDGAR | — |
| 2025-03-27 | 0001021771-25-000066 | EDGAR | — |
272 total filings indexed. 240 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001505497 |
| Ticker | BRTX |
| Exchange | Nasdaq |
| SIC | 8090: Services-Misc Health & Allied Services, NEC |
| Incorporated | NV |
| Website | https://www.biorestorative.com |
| Listed | 1997-12-22 |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report